ICUI ICU Medical, Inc.
ICU Medical, Inc. (ICUI) is expected to report earnings on November 5, 2026, after the market close. The consensus earnings estimate is $1.67 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +0.4% since its last earnings release on August 6, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About ICU Medical, Inc.
ICU Medical Inc is engaged in the development, manufacture and sale of medical devices used in infusion therapy, oncology and critical care applications. Its products include needlefree connectors, nanoclave, chemoclock, chemoclave, and among others.
Sector
Healthcare
Industry
Medical Instruments/Supply